We help our clients to utilize MRI and Dynamic Contrast Enhanced MRI in clinical trials and feasibility studies in inflammatory arthritis or cancer. We do everything related to MRI: from identifying the right clinical sites, training in MRI acquisition, controlling image quality, managing imaging data logistics and analysis, delivering full set of imaging biomarkers and performing post-study data analysis.
We ensure that the effective use of MRI helps reducing the cost of developing new treatments by getting earlier more convincing evidence of treatment effect with smaller patient cohorts, while improving the accuracy of diagnostic assessments and research decisions.
The central part to our service is the use of our proprietary software Dynamika, which comprises cutting edge proprietary algorithms that optimise reading of medical images, giving a precise answer to what effect treatment has had on a patient. With Dynamika we automate medical image analysis to ensure that human bias is taken out of the decision and even slightest variations in disease or patient progress are captured accurately. All analysis and image quality control are done in standardized and objective manner, therefore reducing the possibility of human error and subjective reader variance, whilst increasing workflow efficiency.
Everyone at IA - the scientific advisory board, management and key members of delivery team are world’s recognised experts in MRI analysis, with background in pharmaceutical industry, clinical practice or science. Together, we ensure that our clients in pharmaceutical industry as well as in clinical environment have access to the best advice and service when they need to use MRI in their studies or clinical routine.